Network origin in Xing Bo Gu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Xing Bo Gu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Nanjing University | College/University | Doctorate Degree Doctorate Degree | |
| BANK OF NANJING CO., LTD. | Regional Banks | Director/Board Member | |
| University of Illinois | College/University | Graduate Degree | |
| The University of Western Australia | College/University | Doctorate Degree | |
| China Pharmaceutical University | College/University | Graduate Degree | |
| NANJING SINOLIFE UNITED COMPANY LIMITED | Pharmaceuticals: Other | Director/Board Member | |
| AVIT LTD. | Telecommunications Equipment | Director/Board Member | |
Suzhou Xiangyuan New Materials Co., Ltd.
 Suzhou Xiangyuan New Materials Co., Ltd. Chemicals: SpecialtyProcess Industries Suzhou Xiangyuan New Materials Co., Ltd. principally engages in the research, development, production, and sale of polyurethane chain extenders. Its key products are fine chemical products and new polyurethane chain extenders. The company was founded by Jian Zhou on July 3, 2001 and is headquartered in Suzhou, China. | Chemicals: Specialty | Director/Board Member | |
| Nanyang Technological University | College/University | Graduate Degree | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
| SUZHOU NANOMICRO TECHNOLOGY CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
Genor Biopharma Co., Ltd.
 Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| Stanford University | College/University | Graduate Degree | |
| Yale University | College/University | Graduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Chief Investment Officer | ||
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
| ZHAOKE OPHTHALMOLOGY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| GENOR BIOPHARMA HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
| University of Mississippi | College/University | Masters Business Admin |
Statistics
International
| China | 10 |
| United States | 5 |
| Hong Kong | 4 |
| Cayman Islands | 3 |
| Australia | 2 |
Sectoral
| Consumer Services | 10 |
| Health Technology | 5 |
| Finance | 3 |
| Commercial Services | 3 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 15 |
| Independent Dir/Board Member | 7 |
| Graduate Degree | 5 |
| Doctorate Degree | 3 |
| Corporate Officer/Principal | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Yu Chen | 11 |
| Bo Yu | 4 |
| Bin Qing Xiao | 3 |
| Juan Du | 3 |
| Tao Wen | 2 |
| Tao Wang | 2 |
| Yiou Wang | 2 |
| Chong Bo Xu | 2 |
- Stock Market
- Insiders
- Xing Bo Gu
- Company connections
